he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care.  The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.   
June 16, 2020
Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent 
June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent…
Read More
Biotronik Launchs His-Bundle Pacing Tools
June 16, 2020
Biotronik Launches His-Bundle Pacing Tools
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His-…
Read More
Health Canada and the U.S. Food and Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide.
June 16, 2020
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke
June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat…
Read More
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2
Dave Fornell, Editor
June 15, 2020
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19
June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that…
Read More
At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle, and a still micropunture sheath.
Dave Fornell, Editor
June 10, 2020
Use of Ultrasound to Improve Vascular Access
Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access…
Read More
A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images
June 10, 2020
COVID-19 Genetic PCR Tests Give False Negative Results if Used Too Early
June 10, 2020 — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 (COVID-19) too early…
Read More
SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company of India focused on cardiology, announced it Hydra transcatheter aortic valve replacement (TAVR) device received European CE mark approval. It is indicated for the treatment of patients diagnosed with aortic stenosis. #SMT #HYDRA #TAVR
June 09, 2020
SMT Hydra TAVR System Receives European CE Mark Approval
June 9, 2020 — SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company in India focused on…
Read More
Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.
Dave Fornell, Editor
June 08, 2020
New Technologies Take Cardiac CT to the Next Level
Here is an overview of a few of the biggest technology advances in cardiovascular computed tomography (CT). These are…
Read More
June 08, 2020
Edwards Sapien 3 Transcatheter Heart Valve Receives Approval In China
June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter…
Read More
BD (Becton, Dickinson and Company, and Bard) launched the Halo One Thin-Walled Guiding Sheath, designed to perform as both a guiding sheath and an introducer sheath, for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.
June 08, 2020
BD Launches of Halo One Thin-Walled Guiding Sheath
June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform…
Read More
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).
Dave Fornell, Editor
June 05, 2020
The Cardiovascular Impact of COVID-19
It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger…
Read More
Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational device exemption (IDE) application to start an early feasibility study with a first-in-human trial of the 9 French (Fr) Impella ECP heart pump. Impella ECP, which stands for "expandable cardiac power," will be studied in high-risk percutaneous coronary intervention (PCI) patients.
June 05, 2020
FDA Approves First-in-Human Trial of Impella ECP World’s Smallest Heart Pump
June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational…
Read More
A Philips Healthcare transesophageal echocardiography (TEE) system in use in a hybrid OR.
June 04, 2020
New Guideline Outlines Use of Transesophageal Echo to Assist Surgical Decision-making
June 4, 2020 — Intra-operative transesophageal echocardiography (TEE) is a versatile diagnostic and monitoring tool…
Read More
Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal and renal arterial plus synthetic and/or native arteriovenous hemodialysis fistula. This is a new type of scoring balloon technology.
June 04, 2020
FDA Clears Scoring Sheath That Fits Over Standard Angioplasty Balloons
June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score…
Read More
All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. #COVID19 #SARScov2
Dave Fornell, Editor
June 04, 2020
Most Popular Cardiology Technology Content in May 2020
June 4, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
June 03, 2020
Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework…
Read More
This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. #COVID19
June 02, 2020
How COVID-19 Effects the Brain in Neuroimaging
June 2, 2020 — Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2)…
Read More
he U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiomed Impella RP catheter-based heart pump to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE).  #COVID19 #SARScov2
June 01, 2020
Impella RP Granted FDA Emergency Use Authorization for COVID-19 Patients With Right Heart Failure
June 1, 2020 — The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the…
Read More
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
June 01, 2020
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to an…
Read More
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19. Physio-Control LifePak defibrillator monitor.
May 29, 2020
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19
May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now